Global and United States Angiogenesis Assay Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

Market Analysis and Insights: Global and United States Angiogenesis Assay Market
This report focuses on global and United States Angiogenesis Assay market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Angiogenesis Assay market size is estimated to be worth US$ 20 million in 2022 and is forecast to a readjusted size of US$ 31 million by 2028 with a CAGR of 7.8% during the review period. Fully considering the economic change by this health crisis, by Type, In Vitro Assay Kit accounting for % of the Angiogenesis Assay global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Academic Institution was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.

Global Angiogenesis Assay Scope and Market Size
Angiogenesis Assay market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Angiogenesis Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Angiogenesis Assay market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Angiogenesis Assay market is segmented into
    In Vitro Assay Kit
    In Vivo Assay Kit

Segment by Application, the Angiogenesis Assay market is segmented into
    Academic Institution
    Biotech Companies

Regional and Country-level Analysis
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Angiogenesis Assay Market Share Analysis
Angiogenesis Assay market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiogenesis Assay business, the date to enter into the Angiogenesis Assay market, Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    Abcam
    Bio-Techne
    Thermo Fisher Scientific
    Cell Biolabs, Inc.
    BioVision, Inc
    PromoCell GmbH
    Merck KGaA
    Kollodis BioSciences
    Sartorius (Essen BioScience)
    Creative Bioarray

 1 Study Coverage
    1.1 Angiogenesis Assay Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Angiogenesis Assay Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Angiogenesis Assay Market Size for the Year 2017-2028
        1.2.2 Global Angiogenesis Assay Market Size for the Year 2017-2028
    1.3 Angiogenesis Assay Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Angiogenesis Assay in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Angiogenesis Assay Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Angiogenesis Assay Market Dynamics
        1.4.1 Angiogenesis Assay Industry Trends
        1.4.2 Angiogenesis Assay Market Drivers
        1.4.3 Angiogenesis Assay Market Challenges
        1.4.4 Angiogenesis Assay Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Angiogenesis Assay by Type
    2.1 Angiogenesis Assay Market Segment by Type
        2.1.1 In Vitro Assay Kit
        2.1.2 In Vivo Assay Kit
    2.2 Global Angiogenesis Assay Market Size by Type (2017, 2022 & 2028)
    2.3 Global Angiogenesis Assay Market Size by Type (2017-2028)
    2.4 United States Angiogenesis Assay Market Size by Type (2017, 2022 & 2028)
    2.5 United States Angiogenesis Assay Market Size by Type (2017-2028)

 3 Angiogenesis Assay by Application
    3.1 Angiogenesis Assay Market Segment by Application
        3.1.1 Academic Institution
        3.1.2 Biotech Companies
    3.2 Global Angiogenesis Assay Market Size by Application (2017, 2022 & 2028)
    3.3 Global Angiogenesis Assay Market Size by Application (2017-2028)
    3.4 United States Angiogenesis Assay Market Size by Application (2017, 2022 & 2028)
    3.5 United States Angiogenesis Assay Market Size by Application (2017-2028)

 4 Global Angiogenesis Assay Competitor Landscape by Company
    4.1 Global Angiogenesis Assay Market Size by Company
        4.1.1 Top Global Angiogenesis Assay Companies Ranked by Revenue (2021)
        4.1.2 Global Angiogenesis Assay Revenue by Player (2017-2022)
    4.2 Global Angiogenesis Assay Concentration Ratio (CR)
        4.2.1 Angiogenesis Assay Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Angiogenesis Assay in 2021
        4.2.3 Global Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Angiogenesis Assay Headquarters, Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Angiogenesis Assay Headquarters and Area Served
        4.3.2 Global Angiogenesis Assay Companies Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Angiogenesis Assay Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Angiogenesis Assay Market Size by Company
        4.5.1 Top Angiogenesis Assay Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Angiogenesis Assay Revenue by Players (2020, 2021 & 2022)

 5 Global Angiogenesis Assay Market Size by Region
    5.1 Global Angiogenesis Assay Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Angiogenesis Assay Market Size by Region (2017-2028)
        5.2.1 Global Angiogenesis Assay Market Size by Region: 2017-2022
        5.2.2 Global Angiogenesis Assay Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Angiogenesis Assay Market Size YoY Growth 2017-2028
        6.1.2 North America Angiogenesis Assay Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Angiogenesis Assay Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Angiogenesis Assay Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Angiogenesis Assay Market Size YoY Growth 2017-2028
        6.3.2 Europe Angiogenesis Assay Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Angiogenesis Assay Market Size YoY Growth 2017-2028
        6.4.2 Latin America Angiogenesis Assay Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Angiogenesis Assay Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Angiogenesis Assay Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Abcam
        7.1.1 Abcam Company Details
        7.1.2 Abcam Business Overview
        7.1.3 Abcam Angiogenesis Assay Introduction
        7.1.4 Abcam Revenue in Angiogenesis Assay Business (2017-2022)
        7.1.5 Abcam Recent Development
    7.2 Bio-Techne
        7.2.1 Bio-Techne Company Details
        7.2.2 Bio-Techne Business Overview
        7.2.3 Bio-Techne Angiogenesis Assay Introduction
        7.2.4 Bio-Techne Revenue in Angiogenesis Assay Business (2017-2022)
        7.2.5 Bio-Techne Recent Development
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Company Details
        7.3.2 Thermo Fisher Scientific Business Overview
        7.3.3 Thermo Fisher Scientific Angiogenesis Assay Introduction
        7.3.4 Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2017-2022)
        7.3.5 Thermo Fisher Scientific Recent Development
    7.4 Cell Biolabs, Inc.
        7.4.1 Cell Biolabs, Inc. Company Details
        7.4.2 Cell Biolabs, Inc. Business Overview
        7.4.3 Cell Biolabs, Inc. Angiogenesis Assay Introduction
        7.4.4 Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2017-2022)
        7.4.5 Cell Biolabs, Inc. Recent Development
    7.5 BioVision, Inc
        7.5.1 BioVision, Inc Company Details
        7.5.2 BioVision, Inc Business Overview
        7.5.3 BioVision, Inc Angiogenesis Assay Introduction
        7.5.4 BioVision, Inc Revenue in Angiogenesis Assay Business (2017-2022)
        7.5.5 BioVision, Inc Recent Development
    7.6 PromoCell GmbH
        7.6.1 PromoCell GmbH Company Details
        7.6.2 PromoCell GmbH Business Overview
        7.6.3 PromoCell GmbH Angiogenesis Assay Introduction
        7.6.4 PromoCell GmbH Revenue in Angiogenesis Assay Business (2017-2022)
        7.6.5 PromoCell GmbH Recent Development
    7.7 Merck KGaA
        7.7.1 Merck KGaA Company Details
        7.7.2 Merck KGaA Business Overview
        7.7.3 Merck KGaA Angiogenesis Assay Introduction
        7.7.4 Merck KGaA Revenue in Angiogenesis Assay Business (2017-2022)
        7.7.5 Merck KGaA Recent Development
    7.8 Kollodis BioSciences
        7.8.1 Kollodis BioSciences Company Details
        7.8.2 Kollodis BioSciences Business Overview
        7.8.3 Kollodis BioSciences Angiogenesis Assay Introduction
        7.8.4 Kollodis BioSciences Revenue in Angiogenesis Assay Business (2017-2022)
        7.8.5 Kollodis BioSciences Recent Development
    7.9 Sartorius (Essen BioScience)
        7.9.1 Sartorius (Essen BioScience) Company Details
        7.9.2 Sartorius (Essen BioScience) Business Overview
        7.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Introduction
        7.9.4 Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2017-2022)
        7.9.5 Sartorius (Essen BioScience) Recent Development
    7.10 Creative Bioarray
        7.10.1 Creative Bioarray Company Details
        7.10.2 Creative Bioarray Business Overview
        7.10.3 Creative Bioarray Angiogenesis Assay Introduction
        7.10.4 Creative Bioarray Revenue in Angiogenesis Assay Business (2017-2022)
        7.10.5 Creative Bioarray Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Angiogenesis Assay Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Angiogenesis Assay Market Trends
    Table 3. Angiogenesis Assay Market Drivers
    Table 4. Angiogenesis Assay Market Challenges
    Table 5. Angiogenesis Assay Market Restraints
    Table 6. Global Angiogenesis Assay Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Angiogenesis Assay Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Angiogenesis Assay Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Angiogenesis Assay Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Angiogenesis Assay Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Angiogenesis Assay Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Angiogenesis Assay Revenue Share by Player, 2017-2022
    Table 13. Global Angiogenesis Assay Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Angiogenesis Assay by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2021)
    Table 15. Top Players of Angiogenesis Assay in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Angiogenesis Assay Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Angiogenesis Assay Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Angiogenesis Assay Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Angiogenesis Assay Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Angiogenesis Assay Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Angiogenesis Assay Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Angiogenesis Assay Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Angiogenesis Assay Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Angiogenesis Assay Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Angiogenesis Assay Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Angiogenesis Assay Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Angiogenesis Assay Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abcam Company Details
    Table 31. Abcam Business Overview
    Table 32. Abcam Angiogenesis Assay Product
    Table 33. Abcam Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 34. Abcam Recent Development
    Table 35. Bio-Techne Company Details
    Table 36. Bio-Techne Business Overview
    Table 37. Bio-Techne Angiogenesis Assay Product
    Table 38. Bio-Techne Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 39. Bio-Techne Recent Development
    Table 40. Thermo Fisher Scientific Company Details
    Table 41. Thermo Fisher Scientific Business Overview
    Table 42. Thermo Fisher Scientific Angiogenesis Assay Product
    Table 43. Thermo Fisher Scientific Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 44. Thermo Fisher Scientific Recent Development
    Table 45. Cell Biolabs, Inc. Company Details
    Table 46. Cell Biolabs, Inc. Business Overview
    Table 47. Cell Biolabs, Inc. Angiogenesis Assay Product
    Table 48. Cell Biolabs, Inc. Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 49. Cell Biolabs, Inc. Recent Development
    Table 50. BioVision, Inc Company Details
    Table 51. BioVision, Inc Business Overview
    Table 52. BioVision, Inc Angiogenesis Assay Product
    Table 53. BioVision, Inc Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 54. BioVision, Inc Recent Development
    Table 55. PromoCell GmbH Company Details
    Table 56. PromoCell GmbH Business Overview
    Table 57. PromoCell GmbH Angiogenesis Assay Product
    Table 58. PromoCell GmbH Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 59. PromoCell GmbH Recent Development
    Table 60. Merck KGaA Company Details
    Table 61. Merck KGaA Business Overview
    Table 62. Merck KGaA Angiogenesis Assay Product
    Table 63. Merck KGaA Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 64. Merck KGaA Recent Development
    Table 65. Kollodis BioSciences Company Details
    Table 66. Kollodis BioSciences Business Overview
    Table 67. Kollodis BioSciences Angiogenesis Assay Product
    Table 68. Kollodis BioSciences Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 69. Kollodis BioSciences Recent Development
    Table 70. Sartorius (Essen BioScience) Company Details
    Table 71. Sartorius (Essen BioScience) Business Overview
    Table 72. Sartorius (Essen BioScience) Angiogenesis Assay Product
    Table 73. Sartorius (Essen BioScience) Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 74. Sartorius (Essen BioScience) Recent Development
    Table 75. Creative Bioarray Company Details
    Table 76. Creative Bioarray Business Overview
    Table 77. Creative Bioarray Angiogenesis Assay Product
    Table 78. Creative Bioarray Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million)
    Table 79. Creative Bioarray Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Angiogenesis Assay Product Picture
    Figure 2. Global Angiogenesis Assay Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Angiogenesis Assay Market Size 2017-2028 (US$ Million)
    Figure 4. United States Angiogenesis Assay Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Angiogenesis Assay Market Size 2017-2028 (US$ Million)
    Figure 6. United States Angiogenesis Assay Market Share in Global 2017-2028
    Figure 7. Angiogenesis Assay Report Years Considered
    Figure 8. Product Picture of In Vitro Assay Kit
    Figure 9. Product Picture of In Vivo Assay Kit
    Figure 10. Global Angiogenesis Assay Market Share by Type in 2022 & 2028
    Figure 11. Global Angiogenesis Assay Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Angiogenesis Assay Market Share by Type (2017-2028)
    Figure 13. United States Angiogenesis Assay Market Share by Type in 2022 & 2028
    Figure 14. United States Angiogenesis Assay Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Angiogenesis Assay Market Share by Type (2017-2028)
    Figure 16. Product Picture of Academic Institution
    Figure 17. Product Picture of Biotech Companies
    Figure 18. Global Angiogenesis Assay Market Share by Application in 2022 & 2028
    Figure 19. Global Angiogenesis Assay Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Angiogenesis Assay Market Share by Application (2017-2028)
    Figure 21. United States Angiogenesis Assay Market Share by Application in 2022 & 2028
    Figure 22. United States Angiogenesis Assay Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Angiogenesis Assay Market Share by Application (2017-2028)
    Figure 24. North America Angiogenesis Assay Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. United States Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Angiogenesis Assay Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Angiogenesis Assay Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. China Taiwan Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Latin America Angiogenesis Assay Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 44. Mexico Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Brazil Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Argentina Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Angiogenesis Assay Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Turkey Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Saudi Arabia Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. UAE Angiogenesis Assay Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Abcam Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 52. Bio-Techne Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 54. Cell Biolabs, Inc. Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 55. BioVision, Inc Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 56. PromoCell GmbH Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 57. Merck KGaA Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 58. Kollodis BioSciences Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 59. Sartorius (Essen BioScience) Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 60. Creative Bioarray Revenue Growth Rate in Angiogenesis Assay Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

Market Analysis and Insights: Global and United States Angiogenesis Assay Market
This report focuses on global and United States Angiogenesis Assay market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Angiogenesis Assay market size is estimated to be worth US$ 20 million in 2022 and is forecast to a readjusted size of US$ 31 million by 2028 with a CAGR of 7.8% during the review period. Fully considering the economic change by this health crisis, by Type, In Vitro Assay Kit accounting for % of the Angiogenesis Assay global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Academic Institution was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.

Global Angiogenesis Assay Scope and Market Size
Angiogenesis Assay market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Angiogenesis Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Angiogenesis Assay market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Angiogenesis Assay market is segmented into
    In Vitro Assay Kit
    In Vivo Assay Kit

Segment by Application, the Angiogenesis Assay market is segmented into
    Academic Institution
    Biotech Companies

Regional and Country-level Analysis
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Angiogenesis Assay Market Share Analysis
Angiogenesis Assay market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiogenesis Assay business, the date to enter into the Angiogenesis Assay market, Revenue in Angiogenesis Assay Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    Abcam
    Bio-Techne
    Thermo Fisher Scientific
    Cell Biolabs, Inc.
    BioVision, Inc
    PromoCell GmbH
    Merck KGaA
    Kollodis BioSciences
    Sartorius (Essen BioScience)
    Creative Bioarray